Published in Breast Cancer Res Treat on May 01, 2001
Thymic stromal lymphopoietin fosters human breast tumor growth by promoting type 2 inflammation. J Exp Med (2011) 3.12
OX40 engagement and chemotherapy combination provides potent antitumor immunity with concomitant regulatory T cell apoptosis. J Exp Med (2009) 1.63
The role of OX40-mediated co-stimulation in T-cell activation and survival. Crit Rev Immunol (2009) 1.39
Immunotherapy in the treatment of non-small cell lung cancer. Lung Cancer (2014) 1.35
Signaling through OX40 enhances antitumor immunity. Semin Oncol (2010) 1.27
Adjuvant therapy with agonistic antibodies to CD134 (OX40) increases local control after surgical or radiation therapy of cancer in mice. J Immunother (2010) 1.10
Development and characterization of recombinant human Fc:OX40L fusion protein linked via a coiled-coil trimerization domain. Mol Immunol (2007) 1.03
Ligation of the OX40 co-stimulatory receptor reverses self-Ag and tumor-induced CD8 T-cell anergy in vivo. Eur J Immunol (2009) 1.03
Active vaccination with Dickkopf-1 induces protective and therapeutic antitumor immunity in murine multiple myeloma. Blood (2011) 1.01
OX40 Agonists and Combination Immunotherapy: Putting the Pedal to the Metal. Front Oncol (2015) 1.01
The small molecule TGF-β signaling inhibitor SM16 synergizes with agonistic OX40 antibody to suppress established mammary tumors and reduce spontaneous metastasis. Cancer Immunol Immunother (2011) 0.90
Chemokines, costimulatory molecules and fusion proteins for the immunotherapy of solid tumors. Immunotherapy (2011) 0.89
Age-dependent divergent effects of OX40L treatment on the development of diabetes in NOD mice. Autoimmunity (2016) 0.86
OX40 interactions in gastrointestinal nematode infection. Immunology (2006) 0.81
Integrating costimulatory agonists to optimize immune-based cancer therapies. Immunotherapy (2009) 0.81
UPDATE ON VACCINE DEVELOPMENT FOR RENAL CELL CANCER. Open Access J Urol (2010) 0.77
Update on vaccine development for renal cell cancer. Open Access J Urol (2010) 0.76
Association of OX40L polymorphisms with sporadic breast cancer in northeast Chinese Han population. PLoS One (2012) 0.75
Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. N Engl J Med (1985) 8.21
IL-4 directs the development of Th2-like helper effectors. J Immunol (1990) 7.20
Informal advice- and information-seeking between physicians. J Med Educ (1981) 3.23
Helper T-cell subsets: phenotype, function and the role of lymphokines in regulating their development. Immunol Rev (1991) 3.21
Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses. J Immunol (1998) 2.74
Quantitative analysis of reproducible changes in high-voltage electrophotography. J Altern Complement Med (2001) 2.29
The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure. Ann Thorac Surg (1999) 2.26
CD4+ T cell subsets. Lymphokine secretion of memory cells and of effector cells that develop from precursors in vitro. J Immunol (1990) 2.08
The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion. J Immunol (2000) 2.04
Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg (1998) 1.95
Perioperative blood transfusions are associated with decreased time to recurrence and decreased survival after resection of colorectal liver metastases. Ann Surg (1988) 1.81
Engagement of the OX-40 receptor in vivo enhances antitumor immunity. J Immunol (2000) 1.74
Multicenter review of preoperative risk factors for stroke after coronary artery bypass grafting. Ann Thorac Surg (2000) 1.65
Self-hypnosis reduces anxiety following coronary artery bypass surgery. A prospective, randomized trial. J Cardiovasc Surg (Torino) (1997) 1.64
Use of aprotinin in LVAD recipients reduces blood loss, blood use, and perioperative mortality. Ann Thorac Surg (1995) 1.63
Clinical effects and toxicity of interleukin-2 in patients with cancer. Cancer (1986) 1.60
Health family trees: a tool for finding and helping young family members of coronary and cancer prone pedigrees in Texas and Utah. Am J Public Health (1988) 1.53
A genetically inactivated herpes simplex virus type 2 (HSV-2) vaccine provides effective protection against primary and recurrent HSV-2 disease. J Infect Dis (1997) 1.44
Specimen adequacy in breast fine-needle aspiration biopsy. Am J Clin Pathol (1997) 1.42
Particle assembly incorporating a VP22-BH3 fusion protein, facilitating intracellular delivery, regulated release, and apoptosis. Mol Ther (2003) 1.41
Colorectal cancer in young patients: characteristics and outcome. Am Surg (1994) 1.38
Synchronous colon primaries have the same prognosis as solitary colon cancers. Dis Colon Rectum (1996) 1.29
Molecular cloning of a functional bovine interleukin 2 cDNA. Proc Natl Acad Sci U S A (1986) 1.29
Inappropriate hospitalization of nursing facility residents: a symptom of a sick system of care for frail older people. J Am Geriatr Soc (2000) 1.29
Breast cancer screening: racial/ethnic differences in behaviors and beliefs. J Cancer Educ (1995) 1.23
Engagement of OX40 enhances antigen-specific CD4(+) T cell mobilization/memory development and humoral immunity: comparison of alphaOX-40 with alphaCTLA-4. J Immunol (2001) 1.23
Improved survival in young women with breast cancer. Ann Surg Oncol (1995) 1.21
Augmentation versus inhibition: effects of conjunctional OX-40 receptor monoclonal antibody and IL-2 treatment on adoptive immunotherapy of advanced tumor. J Immunol (2001) 1.19
Screening scale predicts patients successfully receiving long-term implantable left ventricular assist devices. Circulation (1995) 1.16
Optimal timing of revascularization: transmural versus nontransmural acute myocardial infarction. Ann Thorac Surg (2001) 1.14
De novo solid malignancies after cardiac transplantation. Ann Thorac Surg (1995) 1.13
Post-orthodontic retention and post-prosthodontic occlusion in adult complete unilateral and bilateral cleft subjects. Cleft Palate J (1973) 1.10
Outcomes in seriously ill neonates with coarctation of the aorta. A multiinstitutional study. J Thorac Cardiovasc Surg (1994) 1.09
Combined effects of chemotherapy and interleukin 2 in the therapy of mice with advanced pulmonary tumors. Cancer Res (1988) 1.05
The influence of infection on survival and successful transplantation in patients with left ventricular assist devices. J Heart Lung Transplant (1997) 1.03
Inhibition of T-lymphocyte mitogenic responses and effects on cell functions by bovine herpesvirus 1. J Virol (1989) 0.99
The evaluation of an integrated cardiovascular health education and government course in a secondary school. Health Educ (1990) 0.98
Synchronous non-small cell lung cancers. Am J Surg (1996) 0.98
Pitfalls in interpreting prostate specific antigen velocity. J Urol (1996) 0.97
Breast cancer screening behaviors and intentions among asymptomatic women 50 years of age and older. Am J Prev Med (1996) 0.97
Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device. Lancet (1999) 0.96
A new approach to the therapy of cancer based on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2. Surgery (1986) 0.96
Reduction of toxicity of interleukin-2 and lymphokine-activated killer cells in humans by the administration of corticosteroids. J Clin Oncol (1987) 0.95
Duration of left ventricular assist device support affects transplant survival. J Heart Lung Transplant (1996) 0.95
Integrating cardiovascular health education with an English curriculum in a secondary school. J Sch Health (1984) 0.95
Early detection of skin cancer: racial/ethnic differences in behaviors and attitudes. J Cancer Educ (1994) 0.94
Usefulness of the triple test score for palpable breast masses; discussion 1012-3. Arch Surg (2001) 0.94
Effect of corticosteroid on the antitumor activity of lymphokine-activated killer cells and interleukin 2 in mice. Cancer Res (1986) 0.94
Low thromboembolic risk without anticoagulation using advanced-design left ventricular assist devices. Ann Thorac Surg (1996) 0.93
Where, when, and how to detect biased expression of disease-relevant V beta genes in rats with experimental autoimmune encephalomyelitis. J Immunol (1993) 0.92
Cyclosporine-associated end-stage nephropathy after cardiac transplantation: incidence and progression. Transplantation (1997) 0.91
Hypoplastic left heart syndrome: valuing the survival. J Thorac Cardiovasc Surg (2000) 0.90
Long-term outcomes after cardiac transplantation: an experience based on different eras of immunosuppressive therapy. Ann Thorac Surg (2001) 0.90
Comparison of adrenal and extraadrenal pheochromocytomas. Surgery (1993) 0.90
Destruction of the soft palate and nose by tertiary 'benign' syphilis. A case report. J Oral Rehabil (1980) 0.90
Expression of the T-cell activation antigen, OX-40, identifies alloreactive T cells in acute graft-versus-host disease. Blood (1997) 0.89
An efficient selection system for packaging herpes simplex virus amplicons. J Gen Virol (1998) 0.89
Ethical issues in research and publication. J Sch Health (1989) 0.88
Extended indications for lung volume reduction surgery in advanced emphysema. Ann Thorac Surg (1996) 0.88
Cardiopulmonary disease in newborns: a study in continuing medical education. J Med Educ (1979) 0.87
A randomized double-blind study of the effect of triiodothyronine on cardiac function and morbidity after coronary bypass surgery. J Thorac Cardiovasc Surg (1999) 0.87
Quality of life with an implanted left ventricular assist device. Ann Thorac Surg (1997) 0.87
Skin cancer prevention and early detection intentions and behavior. Am J Prev Med (1995) 0.86
Accurate evaluation of palpable breast masses by the triple test score. Arch Surg (1998) 0.86
OX40 ligation enhances cell cycle turnover of Ag-activated CD4 T cells in vivo. Cell Immunol (2001) 0.86
Surgical morbidity in patients with systemic lupus erythematosus. Am J Surg (1989) 0.86
The OX-40 receptor provides a potent co-stimulatory signal capable of inducing encephalitogenicity in myelin-specific CD4+ T cells. Int Immunol (1998) 0.85
Outpatient left ventricular assist device support: a destination rather than a bridge. Ann Thorac Surg (1996) 0.85
Combination gene therapy using multiple immunomodulatory genes transferred by a defective infectious single-cycle herpes virus in squamous cell cancer. Cancer Gene Ther (2000) 0.85
An immunological algorithm to predict risk of high-grade rejection in cardiac transplant recipients. Lancet (1998) 0.85
Examining the immune response in sentinel lymph nodes of mice and men. Eur J Nucl Med (1999) 0.84
Mismatches at the HLA-DR and HLA-B loci are risk factors for acute rejection after lung transplantation. Am J Respir Crit Care Med (1998) 0.84
The state of school heart health education: a review of the literature. Health Educ Q (1980) 0.84
Influence of donor and recipient HLA locus mismatching on development of obliterative bronchiolitis after lung transplantation. Am J Respir Crit Care Med (2001) 0.83
Primary sarcomas of the breast in women under 20 years of age. N Y State J Med (1992) 0.83
Perceived ability versus actual ability: a problem for continuing medical education. Annu Conf Res Med Educ (1977) 0.83
Medium-throughput pKa screening pharmaceuticals by pressure-assisted capillary electrophoresis. Electrophoresis (2001) 0.83
Outcome of anesthesia and surgery in hypothyroid patients. Arch Intern Med (1983) 0.82
Multivariate analysis of factors affecting waiting time to heart transplantation. Ann Thorac Surg (1996) 0.82
Relationships between operative approaches and outcomes in esophageal cancer. Am J Surg (1998) 0.82
Characterization of secreted and intracellular forms of a truncated hepatitis C virus E2 protein expressed by a recombinant herpes simplex virus. J Gen Virol (2003) 0.81
Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genes. Cancer Res (2000) 0.81
Immunity to TCR peptides in multiple sclerosis. II. T cell recognition of V beta 5.2 and V beta 6.1 CDR2 peptides. J Immunol (1994) 0.81
Treatment of relapsing experimental autoimmune encephalomyelitis with T cell receptor peptides. J Neurosci Res (1993) 0.81
Prevention of local recurrence after surgical debulking of nodal and subcutaneous melanoma deposits by hypofractionated radiation. Ann Surg Oncol (2000) 0.80
Bovine interleukin 2: regulatory mechanisms. Vet Immunol Immunopathol (1987) 0.80
Impact of current management practices on early and late death in more than 500 consecutive cardiac transplant recipients. Ann Surg (2000) 0.80
Skin self-examination in a population at increased risk for skin cancer. Am J Prev Med (1994) 0.80
A tissue-type plasminogen activator mutant with prolonged clearance in vivo. Effect of removal of the growth factor domain. J Biol Chem (1988) 0.79
Iliac arterial-enteric fistulas occurring after pelvic irradiation. Surgery (1987) 0.79
CAI at the Ohio State University College of Medicine (1973). Comput Biol Med (1973) 0.79
Immunological and molecular analysis of the sentinel lymph node: a potential approach to predict outcome, tailor therapy, and optimize parameters for tumor vaccine development. J Clin Pharmacol (2001) 0.79
The Delphi technique as a method for determining the continuing education needs of physicians regarding coronary artery disease. J Assoc Hosp Med Educ (1977) 0.78
Screening for breast and prostate cancer: a survey of Texas primary care physicians. Tex Med (1996) 0.78